News from Zyme and the companies we work with.

May 21, 18

Concept Life Sciences ranked in top 20 fastest growing UK pharma companies

PharmaTimes presents Alantra’s Fast 50 ranking of fastest growing, privately-owned pharmaceutical businesses in the UK  Manchester, UK, 21 May 2018: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, is delighted to have placed in the … Continue reading

May 16, 18

BIA Separations and Biomay collaborate on production and purification of large DNA plasmids

Collaboration enables high yield, high purity supercoiled plasmid DNA manufacture for therapeutic application Ajdovšcina, Slovenia and Vienna, Austria, 16 May 2018:   BIA Separations, a leading biochromatography development and manufacturing company, and Biomay, a contact manufacturer of cGMP biopharmaceuticals, today announced a collaboration … Continue reading

May 15, 18

PhoreMost completes $15M (£11M) Series-A round to enter drug discovery

Investment to fund expansion of operations and progression of drug target pipeline Cambridge, UK, 15 May 2018: PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has completed an £11m ($15m) Series-A investment round. The … Continue reading

May 15, 18

Bio-Rad Introduces Anti-Vedolizumab Antibodies

Antibodies Used to Support Research into the Treatment of Ulcerative Colitis and Crohn’s Disease HERCULES, Calif.–May 15, 2018: Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the release … Continue reading

May 15, 18

Applied Photophysics signs agreements with Alfatest and Paralab to expand distribution in Europe

Distributors will supply Chirascan circular dichroism spectrometers and SX stopped-flow spectrometers to Italy, Portugal and Spain Surrey (UK), Rome (Italy) and Valbom (Portugal) – May 15, 2018:   Applied Photophysics, a leading provider of systems for biophysical characterization of biomolecules, today announced … Continue reading

May 9, 18

TTP plc and Camena Bioscience partner to create novel metabolite analyser

Cambridge, UK, 09 May 2018:    TTP Plc (TTP), a leading independent technology and product development company, and Camena Bioscience, a developer of pioneering technology that profiles small molecules, such as metabolites, nutrients or medicines in liquid samples, announced today that … Continue reading

May 9, 18

SYGNIS introduces 2view unique Western blot detection technology

Offers two modes of detection from a single antibody Fast visible detection of analytes at nanogram level Enhanced chemi-luminescence detection down to picogram level Easy to use with a single incubation Heidelberg, Germany and Cambridge, UK, 09 May 2018 – SYGNIS AG  … Continue reading

May 8, 18

Horizon Discovery appoints Terry Pizzie as Chief Executive Officer

Cambridge, UK, 08 May 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Group” or “the Company”), a global leader in gene editing and gene modulation technologies, is pleased to announce the appointment of Terry Pizzie as Chief Executive Officer and Board … Continue reading

May 8, 18

SYGNIS completes acquisition of TGR Biosciences

Heidelberg, Germany and Cambridge, UK, 08 May 2018 – SYGNIS AG    (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the completion of the acquisition of TGR Biosciences (TGR), the Australian research reagents company. TGR and its highly complementary technologies and products along … Continue reading

May 2, 18

IONTAS and aTen Therapeutics announce collaboration to discover therapeutic oncology leads

Cambridge, UK and Edinburgh, UK, 02 May 2018: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, and aTen Therapeutics Limited (aTen), a private biopharmaceutical company developing next-generation antibodies for the treatment of cancer, announced today … Continue reading